First Light Acquisition Group, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net income was USD 3.53 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.242 USD | +3.60% | +4.31% | -83.97% |
Apr. 16 | Calidi Biotherapeutics Prices $6.1 Million Offering | MT |
Mar. 21 | H.C. Wainwright Lowers Price Target on Calidi Biotherapeutics to $2 From $11, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-83.97% | 11.44M | |
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |
- Stock Market
- Equities
- CLDI Stock
- News Calidi Biotherapeutics, Inc.
- First Light Acquisition Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022